Prevention of diabetes with rosiglitazone: Evidence of benefit or unexpected harm?

Med Hypotheses. 2008;70(1):199-200. doi: 10.1016/j.mehy.2007.07.035. Epub 2007 Sep 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use*

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone